Version 2 2024-11-12, 01:42Version 2 2024-11-12, 01:42
Version 1 2023-10-24, 23:45Version 1 2023-10-24, 23:45
thesis
posted on 2024-11-12, 01:42authored byMAGDALENA KUCHTA
This thesis investigated the cGMP signalling pathway via CNP/GC-B as a new therapeutic option for benign prostatic hyperplasia. Expression analyses showed that in prostatic smooth muscle cells, CNP/GC-B components are higher expressed than others, such as GC-A or sGC. Furthermore, CNP treatment delayed the growth of HPrSMCs. Ex vivo experiments with a rat model demonstrated that CNP and its analogue VNP led to significant relaxation of the prostate glands. As both characteristics of BPH (increased proliferation and muscle tone) can be addressed by the CNP/GC-B pathway, it presents another option for the treatment of BPH.
History
Principal supervisor
Betty Exintaris
Additional supervisor 1
Michael Whittaker
Additional supervisor 2
Kate Loveland
Additional supervisor 3
Ralf Middendorff
Additional supervisor 4
Nikola-Michael Prpic-Schäper
Year of Award
2023
Department, School or Centre
Central Clinical School
Additional Institution or Organisation
Molecular and Translational Science (Hudson Institute)
Campus location
Australia
Course
Doctor of Philosophy (Joint PhD with Justus Liebig University Giessen - International)